Venetoclax

SUSPENDED · PHASE1 · Acute Myeloid Leukemia

Other - Pending amendment for study expansion.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.